Evidence map›Paper›PMID 31185617›Full record

ArticleMolecules (Basel, Switzerland)2019

Synthesis and Biological Evaluation of

Yaping Hu, Binfeng Chen, Zaiqiang Lei, Hongqian Zhao, Hongxi Zhu, Peng Quan, Yongshou Tian

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Triflamides and Triflimides: Synthesis and Applications.Molecules (Basel, Switzerland) · 2022
    Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yaping HuKey Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China. hyp910309@163.com.
Binfeng ChenKey Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China. yh_cbf@163.com.
Zaiqiang LeiKey Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China. ZaiqiangLei@126.com.
Hongqian ZhaoKey Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China. zhaohongqian999@163.com.
Hongxi ZhuKey Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China. 13125557362@163.com.
Peng QuanSchool of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China. quanpeng81@163.com.
Yongshou TianKey Laboratory of Structure-Based Drug Design and Discovery, Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China. tianys@syphu.edu.cn.
Shenyang Pharmaceutical University · CN

Funding

Foundation of Shenyang Science and Technology Bureau NO. F13-196-9-00
6 · The paper itself

Abstract

A series of

Indexed as

Antiviral AgentsEnzyme InhibitorsHumansInfluenza A Virus, H5N1 SubtypeInhibitory Concentration 50Microsomes, LiverMolecular Docking SimulationNeuraminidaseOseltamivirAntiviral AgentsEnzyme InhibitorsNeuraminidaseOseltamivirinfluenzaneuraminidase inhibitorsoseltamivir analogues

Identifiers

PMID31185617
PMCPMC6600469
OpenAlexW2950938884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.